Bodycote (BYPLF)
(Delayed Data from OTC)
$9.28 USD
0.00 (0.00%)
Updated Jul 17, 2024 01:37 PM ET
3-Hold of 5 3
C Value B Growth NA Momentum NA VGM
Income Statements
Fiscal Year end for Bodycote falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 998 | 920 | 847 | 768 | 919 |
Cost Of Goods | 850 | 799 | 733 | 687 | 754 |
Gross Profit | 148 | 120 | 114 | 81 | 165 |
Selling & Adminstrative & Depr. & Amort Expenses | 0 | -6 | -2 | 74 | 1 |
Income After Depreciation & Amortization | 148 | 126 | 115 | 6 | 164 |
Non-Operating Income | 1 | 0 | 0 | 0 | 0 |
Interest Expense | 10 | 9 | 9 | 9 | 6 |
Pretax Income | 139 | 118 | 107 | -2 | 158 |
Income Taxes | 31 | 26 | 24 | -3 | 38 |
Minority Interest | 1 | 1 | 1 | 1 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 108 | 92 | 83 | 1 | 120 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 106 | 91 | 82 | 1 | 120 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 250 | 230 | 230 | 124 | 272 |
Depreciation & Amortization (Cash Flow) | 102 | 104 | 115 | 118 | 108 |
Income After Depreciation & Amortization | 148 | 126 | 115 | 6 | 164 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 190.88 | 190.93 | 190.71 | 200.00 | 190.72 |
Diluted EPS Before Non-Recurring Items | 0.60 | 0.53 | 0.49 | -0.36 | 0.66 |
Diluted Net EPS (GAAP) | 0.56 | 0.48 | 0.43 | 0.00 | 0.63 |
Fiscal Year end for Bodycote falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | NA | NA | NA | NA | NA |
Cost Of Goods | NA | NA | NA | NA | NA |
Gross Profit | NA | NA | NA | NA | NA |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Non-Operating Income | NA | NA | NA | NA | NA |
Interest Expense | NA | NA | NA | NA | NA |
Pretax Income | NA | NA | NA | NA | NA |
Income Taxes | NA | NA | NA | NA | NA |
Minority Interest | NA | NA | NA | NA | NA |
Investment Gains/Losses | NA | NA | NA | NA | NA |
Other Income/Charges | NA | NA | NA | NA | NA |
Income From Cont. Operations | NA | NA | NA | NA | NA |
Extras & Discontinued Operations | NA | NA | NA | NA | NA |
Net Income (GAAP) | NA | NA | NA | NA | NA |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | NA | NA | NA | NA | NA |
Diluted EPS Before Non-Recurring Items | NA | NA | NA | NA | NA |
Diluted Net EPS (GAAP) | NA | NA | NA | NA | NA |